Who is sponsoring NCT03992742?

NCT03992742 is sponsored by The University of Hong Kong.

What drugs are being tested in NCT03992742?

Interventions in NCT03992742: Initial phase: personalized instant messaging (PIM), Second phase: optional cocktail interventions (OCI), Initial phase: regular instant messaging (RIM), Second phase: personalized instant messaging (PIM), AWARD advice, Warning leaflet, Referral card, COSH booklet.

What condition does NCT03992742 study?

NCT03992742 studies Smoking Cessation.

Is NCT03992742 still recruiting?

NCT03992742 is currently status unknown. Last updated 20 August 2020.

Last reviewed 2020-08-20 · How we verify

NCT03992742

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Building Capacity and Promoting Smoking Cessation in the Community Via "Quit to Win" Contest 2019

Status unknown NA Last updated 20 August 2020

What this trial tests

NA trial testing Initial phase: personalized instant messaging (PIM) in Smoking Cessation in 1,200 participants. Status unknown.

Timeline

21 June 2019

Primary endpoint
30 June 2020

30 June 2021

Quick facts

Lead sponsor	The University of Hong Kong
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	1,200
Start date	21 June 2019
Primary completion	30 June 2020
Estimated completion	30 June 2021
Sites	1 location across Hong Kong

Drugs / interventions tested

Initial phase: personalized instant messaging (PIM)
Second phase: optional cocktail interventions (OCI)
Initial phase: regular instant messaging (RIM)
Second phase: personalized instant messaging (PIM)
AWARD advice
Warning leaflet
Referral card
COSH booklet

Conditions studied

Smoking Cessation — all drugs for Smoking Cessation →

Sponsor

The University of Hong Kong

Who can join

18 and older, any sex, with Smoking Cessation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study will examine (1) effectiveness of a combined intervention of AWARD advice, active referral, instant messaging and optional cocktail intervention to increase abstinence using a sequential multiple assignment randomised trial (SMART) and (2) explore the use of CBPR model to build capacity and to engage community partners in taking on this important public health issue for sustainability in the community. In addition, a process evaluation will be conducted to assess the effectiveness of the recruitment activity and how it is linked with the overall program outcomes.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

High Perceived Susceptibility to and Severity of COVID-19 in Smokers Are Associated with Quitting-Related Behaviors.
Li Y, Luk TT, Wu Y, Cheung DYT, et al · · 2021 · cited 11× · PMID 34682641 · DOI 10.3390/ijerph182010894
Adaptive interventions to optimise the mobile phone-based smoking cessation support: study protocol for a sequential, multiple assignment, randomised trial (SMART).
Zhao SZ, Weng X, Luk TT, Wu Y, et al · · 2022 · cited 7× · PMID 35982468 · DOI 10.1186/s13063-022-06502-7
Associations of changes in smoking-related practices with quit attempt and smoking consumption during the COVID-19 pandemic: A mixed-methods study.
Zeng Y, Luk TT, Wu YS, Tong SCΗ, et al · · 2022 · cited 3× · PMID 36588925 · DOI 10.18332/tid/156454

Verify or expand the search:

Other recruiting trials for Smoking Cessation

Currently open trials in the same condition.

NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
NCT07224087 — Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients · Phase 1 · recruiting
NCT07331519 — Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer · NA · recruiting
NCT07210567 — Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors · NA · recruiting
NCT07129590 — Trauma-Informed Care for Smoking Cessation for Pregnancy · NA · recruiting

Other The University of Hong Kong trials

Trials by the same sponsor.

NCT05981430 — Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae · NA · not yet recruiting
NCT07478757 — Assessing the Effectiveness of Low-Dose Computed Tomography in Lung Cancer Screening for High-Risk Smokers: A Randomized · NA · not yet recruiting
NCT07448649 — Chatbot-Assisted Advance Care Planning Education for Family Members · NA · not yet recruiting
NCT07484932 — TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer · NA · not yet recruiting
NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03992742 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Hong Kong
Last refreshed: 20 August 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03992742.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing